0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug Therapy
 61-80 of 1661 Articles
JAMA Otolaryngology–Head & Neck Surgery | 
Continued Learning | 
Steven M. Houser, MD; Catherine Weng, MD; Yi-Chun Liu, MD
JAMA Otolaryngol Head Neck Surg. 2015;141(4):382-385. doi:10.1001/jamaoto.2015.8.

JAMA Internal Medicine | 
Research Letter | 
Paolo Goffredo, MD; Samantha M. Thomas, MB; Michaela A. Dinan, PhD; et al.
JAMA Intern Med. 2015;175(4):638-640. doi:10.1001/jamainternmed.2014.8020.

JAMA Dermatology | 
Review | 
April W. Armstrong, MD, MPH; Jerry Bagel, MD; Abby S. Van Voorhees, MD; et al.
JAMA Dermatol. 2015;151(4):432-438. doi:10.1001/jamadermatol.2014.3456.

JAMA Neurology | 
Viewpoint | 
Carmen Kut, BS; Stuart A. Grossman, MD; Jaishri Blakeley, MD
JAMA Neurol. 2015;72(4):381-382. doi:10.1001/jamaneurol.2014.3736.

JAMA Neurology | 
Editorial | 
Olaf Stüve, MD, PhD; Diego Centonze, MD, PhD
JAMA Neurol. 2015;72(4):387-389. doi:10.1001/jamaneurol.2014.4494.

JAMA Neurology | 
Original Investigation | 
Anna He, MBBS; Tim Spelman, MBBS, MSc; Vilija Jokubaitis, PhD; et al.
JAMA Neurol. 2015;72(4):405-413. doi:10.1001/jamaneurol.2014.4147.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Perspective | 
Say Salomon, MD; James Fausto, MD
JAMA Intern Med. 2015;175(4):487. doi:10.1001/jamainternmed.2014.7690.

JAMA Pediatrics | 
Editorial | 
Andrea J. Apter, MD, MSc, MA
JAMA Pediatr. 2015;169(4):310-311. doi:10.1001/jamapediatrics.2014.3661.

JAMA Pediatrics | 
Original Investigation | 
Bruce G. Bender, PhD; Peter J. Cvietusa, MD; Glenn K. Goodrich, MS; et al.
JAMA Pediatr. 2015;169(4):317-323. doi:10.1001/jamapediatrics.2014.3280.
Includes: Supplemental Content

JAMA Dermatology | 
Observation | 
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.
JAMA Dermatol. 2015;151(4):453-454. doi:10.1001/jamadermatol.2014.4529.

JAMA | 
From the JAMA Network | 
Mark Olfson, MD, MPH
JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743.

JAMA | 
Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2015;313(12):1199. doi:10.1001/jama.2015.2195.

JAMA Dermatology | 
Editorial |  ONLINE FIRST
Emmy M. Graber, MD, MBA
JAMA Dermatol. Published online March 22, 2015. doi:10.1001/jamadermatol.2015.35

JAMA | 
The JAMA Forum |  FREE
Austin B. Frakt, PhD
JAMA. 2015;313(11):1091-1092. doi:10.1001/jama.2015.0544.

JAMA | 
Original Investigation |  FREE
Hongmei Nan, MD, PhD; Carolyn M. Hutter, MS, PhD; Yi Lin, MS; et al.
JAMA. 2015;313(11):1133-1142. doi:10.1001/jama.2015.1815.
Includes: Supplemental Content

JAMA | 
Global Health | 
M. J. Friedrich
JAMA. 2015;313(11):1093. doi:10.1001/jama.2015.1096.

JAMA | 
From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2015;313(10):1052-1053. doi:10.1001/jama.2015.1302.

JAMA | 
Viewpoint | 
J. Robert Powell, PharmD
JAMA. 2015;313(10):1013-1014. doi:10.1001/jama.2015.59.

JAMA | 
Viewpoint | 
Om P. Ganda, MD
JAMA. 2015;313(10):1009-1010. doi:10.1001/jama.2015.216.

JAMA | 
Viewpoint | 
Connie B. Newman, MD; Jonathan A. Tobert, MD, PhD
JAMA. 2015;313(10):1011-1012. doi:10.1001/jama.2015.1335.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Viewpoint  | 
Evaluation of Flibanserin Science and Advocacy at the FDA
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH